High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study

被引:31
作者
Asztalos, BF [1 ]
机构
[1] Tufts Univ, Lipid Metab Lab, HNRCA, Boston, MA 02111 USA
关键词
high-density lipoprotein; high-density lipoprotein subspecies; atherosclerosis; anti-atherogenicity;
D O I
10.1097/01.hco.0000126979.41946.7e
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The purpose of this review is to summarize the current understanding of the potentially antiatherogenic properties of high-density lipoprotein related to its different components. Recent findings Recent findings on the role of the different high-density lipoprotein subspecies in reverse cholesterol transport, inflammation, endothelial dysfunction, and low-density lipoprotein oxidation are covered. Special emphasis is put on the heterogeneity of high-density lipoprotein and functional changes related to specific high-density lipoprotein particles with the potential therapeutic alterations of high-density lipoprotein metabolism. Summary The diverse action of high-density lipoprotein observed could be explained by the heterogeneity of high-density lipoprotein particles with completely different composition and properties. The modification of specific high-density lipoprotein subpopulations to reach the maximum atheroprotective effects under various pathologic conditions bears great potential in lipid research.
引用
收藏
页码:385 / 391
页数:7
相关论文
共 86 条
[1]   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[2]   Atheroprotective effects of high-density lipoproteins [J].
Assmann, G ;
Nofer, JR .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :321-341
[3]   Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations [J].
Asztalos, BF ;
Lefevre, M ;
Foster, TA ;
Tulley, R ;
Windhauser, M ;
Wong, L ;
Roheim, PS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :1885-1893
[4]   Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency [J].
Asztalos, BF ;
Horvath, KV ;
Kajinami, K ;
Nartsupha, C ;
Cox, CE ;
Batista, M ;
Schaefer, EJ ;
Inazu, A ;
Mabuchi, H .
JOURNAL OF LIPID RESEARCH, 2004, 45 (03) :448-455
[5]   Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients [J].
Asztalos, BF ;
Horvath, KV ;
McNamara, JR ;
Roheim, PS ;
Rubinstein, JJ ;
Schaefer, EJ .
JOURNAL OF LIPID RESEARCH, 2002, 43 (10) :1701-1707
[6]   Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients [J].
Asztalos, BF ;
Horvath, KV ;
McNamara, JR ;
Roheim, PS ;
Rubinstein, JJ ;
Schaefer, EJ .
ATHEROSCLEROSIS, 2002, 164 (02) :361-369
[7]   Change in α1 HDL concentration predicts progression in coronary artery stenosis [J].
Asztalos, BF ;
Batista, M ;
Horvath, KV ;
Cox, CE ;
Dallal, GE ;
Morse, JS ;
Brown, GB ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) :847-852
[8]   Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease [J].
Asztalos, BF ;
Brousseau, ME ;
McNamara, JR ;
Horvath, KV ;
Roheim, PS ;
Schaefer, EJ .
ATHEROSCLEROSIS, 2001, 156 (01) :217-225
[9]   Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease [J].
Asztalos, BF ;
Roheim, PS ;
Milani, RL ;
Lefevre, M ;
McNamara, JR ;
Horvath, KV ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2670-2676
[10]   Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells [J].
Barter, PJ ;
Baker, PW ;
Rye, KA .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (03) :285-288